US Patent 10131713 HER2/neu-specific antibodies and methods of using same
Patent 10131713 was granted and assigned to MacroGenics on November, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 15, 2016
Date of Patent
November 20, 2018
Patent Applicant
Patent Application Number
15266421
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10131713 HER2/neu-specific antibodies and methods of using same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
